← Back to Search

Catheterization for Preventing Urinary Tract Infections

N/A
Waitlist Available
Led By Emily G Parent, D.O.
Research Sponsored by Abington Memorial Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The patient must be female.
The patient must be 18 years of age or older.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-4 weeks
Awards & highlights

Study Summary

This trial will look at whether or not catheterization during short surgeries is necessary and if it leads to an increased risk of postoperative urinary tract infections.

Who is the study for?
This trial is for women over 18 who are having certain short gynecologic procedures like D&C, hysteroscopies, and LEEP. They must be under general anesthesia or monitored care without pre-op antibiotics, not on chronic UTI therapy or immunosuppressants, and haven't had a catheter in the last 6 months.Check my eligibility
What is being tested?
The study is testing if skipping bladder catheterization during short gynecologic surgeries can reduce urinary tract infections after surgery. Women will either have straight catheterization as usual or none at all to see which method leads to fewer infections.See study design
What are the potential side effects?
Since this trial involves standard surgical procedures with or without catheterization, side effects may include typical postoperative discomforts such as temporary pain at the surgery site but specific side effects related to avoiding catheter use are being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.
Select...
I am 18 years old or older.
Select...
I will be under general anesthesia or monitored sedation for my procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postoperative Bacteriuria
Secondary outcome measures
Subjective urinary tract discomfort
Other outcome measures
Symptomatic urinary tract infection

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Straight catheterization (control)Experimental Treatment1 Intervention
The control arm is the current practice at our hospital (to perform straight catheterization for short procedures).
Group II: No straight catheterizationActive Control1 Intervention
The experimental arm will void preoperatively and will not be straight catheterized intraoperatively. This is a change from the current practice at our hospital.

Find a Location

Who is running the clinical trial?

Abington Memorial HospitalLead Sponsor
11 Previous Clinical Trials
3,915 Total Patients Enrolled
Emily G Parent, D.O.Principal InvestigatorAbington Memorial Hospital

Media Library

Straight catheterization Clinical Trial Eligibility Overview. Trial Name: NCT01926756 — N/A
Urinary Tract Infection Research Study Groups: Straight catheterization (control), No straight catheterization
Urinary Tract Infection Clinical Trial 2023: Straight catheterization Highlights & Side Effects. Trial Name: NCT01926756 — N/A
Straight catheterization 2023 Treatment Timeline for Medical Study. Trial Name: NCT01926756 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrolment opportunities for this medical experiment?

"Data from clinicaltrials.gov reveals that this medical trial has concluded patient recruitment; the study was first posted on July 1st 2013 and last edited August 20th 2013. However, there are presently seven other trials actively seeking participants for enrollment."

Answered by AI
~17 spots leftby Apr 2025